Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PANG KS")

Results 1 to 11 of 11

  • Page / 1
Export

Selection :

  • and

SEQUENTIAL FIRST-PASS ELIMINATION OF A METABOLITE DERIVED FROM A PRECURSORPANG KS; GILLETTE JR.1979; J. PHARMACOKINET. BIOPHARMACEUT.; GBR; DA. 1979; VOL. 7; NO 3; PP. 275-290; BIBL. 13 REF.Article

HEPATIC CLEARANCE OF DRUGS. I. THEORETICAL CONSIDERATIONS OF A "WELL-STIRRED" MODEL AND A "PARALLEL TUBE" MODEL. INFLUENCE OF HEPATIC BLOOD FLOW, PLASMA AND BLOOD CELL BINDING, AND THE HEPATOCELLULAR ENZYMATIC ACTIVITY ON HEPATIC DRUG CLEARANCE.PANG KS; ROWLAND M.1977; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1977; VOL. 5; NO 6; PP. 625-653; BIBL. 1 P. 1/2Article

HEPATIC CLEARANCE OF DRUGS. II. EXPERIMENTAL EVIDENCE FOR ACCEPTANCE OF THE "WELL STIRRED" MODEL OVER THE "PARALLEL TUBE" MODEL USING LIDOCAINE IN THE PERFUSED RAT LIVER IN SITU PREPARATION.PANG KS; ROWLAND M.1977; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1977; VOL. 5; NO 6; PP. 655-680; BIBL. 28 REF.Article

CONJUGATION KINETICS OF ACETAMINOPHEN BY THE PERFUSED RAT LIVER PREPARATIONPANG KS; TERRELL JA.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 14; PP. 1959-1965; BIBL. 18 REF.Article

METABOLITE PHARMACOKINETICS: METHODS FOR SIMULTANEOUS ESTIMATES OF ELIMINATION RATE CONSTANTS OF A DRUG AND ITS METABOLITE: A COMMENTARYPANG KS; GILLETTE JR.1980; DRUG METABOL. DISPOSIT.; USA; DA. 1980; VOL. 8; NO 1; PP. 39-44; BIBL. 3 REF.Article

HEPATIC CLEARANCE OF DRUGS. III. ADDITIONAL EXPERIMENTAL EVIDENCE SUPPORTING THE "WELL-STIRRED" MODEL, USING METABOLITE (MEGX) GENERATED FROM LIDOCAINE UNDER VARYING HEPATIC BLOOD FLOW RATES AND LINEAR CONDITIONS IN THE PERFUSED.PANG KS; ROWLAND M.1977; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1977; VOL. 5; NO 6; PP. 681-699; BIBL. 14 REF.Article

KINETIES OF METABOLITE FORMATION AND ELIMINATION IN THE PERFUSED RAT LIVER PREPARATION: DIFFERENCES BETWEEN THE ELIMINATION OF PREFORMED ACETAMINOPHEN AND ACETAMINOPHEN FORMED FROM PHENACETINPANG KS; GILLETTE JR.1978; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1978; VOL. 207; NO 1; PP. 178-194; BIBL. 1 P.Article

A THEORETICAL EXAMINATION OF THE EFFECTS OF GUT WALL METABOLISM, HEPATIC ELIMINATION, AND ENTEROHEPATIC RECYCLING ON ESTIMATES OF BIOAVAILABILITY AND OF HEPATIC BLOOD FLOWPANG KS; GILLETTE JR.1978; J. PHARMACOKINET. BIOPHARMACEUT.; GBR; DA. 1978; VOL. 6; NO 5; PP. 355-367; BIBL. 5 REF.Article

A METHOD FOR THE ESTIMATION OF THE FRACTION OF A PRECURSOR THAT IS CONVERTED TO A METABOLITE IN RAT IN VIVO WITH PHENACETIN AND ACETAMINOPHENPANG KS; STROBL K; GILLETTE JR et al.1979; DRUG METABOL. DISPOSIT.; USA; DA. 1979; VOL. 7; NO 6; PP. 366-372; BIBL. 16 REF.Article

METABOLITE KINETICS: FORMATION OF ACETAMINOPHEN FROM DEUTERATED AND NONDEUTERATED PHENACETIN AND ACETANILIDE ON ACETAMINOPHEN SULFATION KINETICS IN THE PERFUSED RAT LIVER PREPARATIONPANG KS; WALLER L; HORNING MG et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 222; NO 1; PP. 14-19; BIBL. 23 REF.Article

KINETICS OF SULFATION AND GLUCURONIDATION OF HARMOL IN THE PERFUSED RAT LIVER PREPARATION: DISAPPEARANCE OF ABERRANCES IN GLUCURONIDATION KINETICS BY INHIBITION OF SULFATIONKOSTER H; HALSEMA I; SCHOLTENS E et al.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 19; PP. 3023-3028; BIBL. 22 REF.Article

  • Page / 1